ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $305,861 | -79.9% | 85,436 | -79.2% | 0.00% | -100.0% |
Q2 2023 | $1,518,870 | +3026.9% | 411,618 | +2704.9% | 0.00% | – |
Q1 2023 | $48,574 | -92.9% | 14,675 | -91.7% | 0.00% | – |
Q4 2022 | $682,337 | +488.2% | 175,860 | +267.6% | 0.00% | – |
Q3 2022 | $116,000 | +300.0% | 47,838 | +226.9% | 0.00% | – |
Q2 2022 | $29,000 | -97.5% | 14,633 | -97.7% | 0.00% | – |
Q1 2022 | $1,143,000 | +618.9% | 624,366 | +455.6% | 0.00% | – |
Q4 2021 | $159,000 | +160.7% | 112,387 | +108.5% | 0.00% | – |
Q3 2021 | $61,000 | -48.3% | 53,906 | -26.9% | 0.00% | – |
Q2 2021 | $118,000 | +195.0% | 73,777 | +226.3% | 0.00% | – |
Q1 2021 | $40,000 | -16.7% | 22,612 | +12.7% | 0.00% | – |
Q3 2020 | $48,000 | +60.0% | 20,056 | +92.8% | 0.00% | – |
Q2 2020 | $30,000 | -70.6% | 10,400 | -70.6% | 0.00% | – |
Q1 2020 | $102,000 | -84.4% | 35,333 | -78.4% | 0.00% | -100.0% |
Q4 2019 | $654,000 | +9.4% | 163,491 | +21.7% | 0.00% | 0.0% |
Q3 2019 | $598,000 | +164.6% | 134,295 | +130.1% | 0.00% | – |
Q2 2019 | $226,000 | +27.7% | 58,374 | +25.1% | 0.00% | – |
Q1 2019 | $177,000 | – | 46,663 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
Renaissance Technologies | 20,300 | $63,000 | 0.00% |
ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |